GLP-1 Market
LLY $1184.78 ▲ +0.1% NVO $38.71 ▼ -0.2% PFE $28.72 ▲ +0.2% VKTX $33.03 ▼ -7.1% KLRA $11.12 ▼ -0.9% GPCR $35.06 ▼ -2.4% RHHBY $53.34 ▼ -2.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Immedate Release Torsemide

Company
Sarfez Pharmaceuticals, Inc.
Mechanism
Mechanism not yet reported
Route
Oral
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 29, 2026

Trial details
  • Completed NCT NCT03214874

    Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects

    Not yet reported Sarfez Pharmaceuticals, Inc. 24 participants Est. completion 2017-07-20 1 site
    Heart failureChronic kidney disease
    View official trial listing →
  • Withdrawn NCT NCT06708611

    A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs

    Not yet reported Sarfez Pharmaceuticals, Inc. Est. completion 2025-03-25 1 site
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT06995144

    Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure

    Not yet reported Sarfez Pharmaceuticals, Inc. Est. completion 2026-09-16 1 site
    Heart failure Other conditions: Edema, Pulmonary Congestion, Fluid Overload
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Immedate Release Torsemide, Immedate Release Torsemide Tablets, IR Torsemide

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.